OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with Myelofibrosis
Surya K. De
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1355-1360
Closed Access | Times Cited: 8
Surya K. De
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 12, pp. 1355-1360
Closed Access | Times Cited: 8
Showing 8 citing articles:
Synthetic Approaches to the New Drugs Approved During 2022
Scott P. France, Erick A. Lindsey, Emma L. McInturff, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4376-4418
Closed Access | Times Cited: 9
Scott P. France, Erick A. Lindsey, Emma L. McInturff, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4376-4418
Closed Access | Times Cited: 9
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Youlong Du, Anas Semghouli, Qian Wang, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Youlong Du, Anas Semghouli, Qian Wang, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseases
Tong Li, Xianjing Yang, Juan Zhu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110660-110660
Closed Access | Times Cited: 12
Tong Li, Xianjing Yang, Juan Zhu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110660-110660
Closed Access | Times Cited: 12
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship
Lalmohan Maji, Sindhuja Sengupta, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Lalmohan Maji, Sindhuja Sengupta, Gurubasavaraja Swamy Purawarga Matada, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 8
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 8
Modulating the immune system as a therapeutic target for myelodysplastic syndromes and acute myeloid leukemia
Caroline M. Putnam, Lahari Kondeti, Meredith B. A. Kesler, et al.
Biochemistry and Cell Biology (2023) Vol. 101, Iss. 6, pp. 481-495
Open Access | Times Cited: 5
Caroline M. Putnam, Lahari Kondeti, Meredith B. A. Kesler, et al.
Biochemistry and Cell Biology (2023) Vol. 101, Iss. 6, pp. 481-495
Open Access | Times Cited: 5
Interleukin-1 Receptor-Associated Kinase 1 in Cancer Metastasis and Therapeutic Resistance: Mechanistic Insights and Translational Advances
Mariana K. Najjar, Munazza S. Khan, Chuling Zhuang, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1690-1690
Open Access
Mariana K. Najjar, Munazza S. Khan, Chuling Zhuang, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1690-1690
Open Access
Development of a Rapid Lc-Ms/Ms Method and its Application for the Pharmacokinetic Analysis of Pacritinib in Rats
Ya Wu, Luo yi Huang, Jing huan Ni, et al.
(2023)
Closed Access
Ya Wu, Luo yi Huang, Jing huan Ni, et al.
(2023)
Closed Access
